Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 6 results for "claris otsuka ltd"

Claris to buy-back 14.49% stake for Rs 231.25 cr

-based pharmaceutical firm Claris Lifesciences will buy-back shares aggregating 14.49 per cent of its total equity capital from shareholders for a total of Rs 231.25 crore. The company said it will buy-back up to 92.5 lakh shares of face value Rs 10 ... Business Standard India, 4 weeks ago

Claris Lifesciences consolidated net profit at Rs. 18 cr in Q4

Claris Lifesiciences, a Rs. 650 crore pharmaceutical company from Ahmedabad, has posted consolidated net profit of Rs. 17.75 crore during the fourth quarter ended December 2013 from Rs. 25.19 crore in the corresponding period of last year. These ...
 PharmaBiz1 month ago

Hiring activity in pharma sector grows at modest two per cent in Feb'14 over Jan'14

Naukri Job Speak Index for the month of February 14 reflects muted growth for the pharmaceutical sector. An month-over-month analysis reveals that index has grown by two per cent in February 2014 over January 2014. Yearly comparison shows a nine per ...
 Express Pharma1 month ago

Global Clinical Nutrition Products Industry

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for ...
 Digital Journal1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less